Evidence map›Paper›PMID 42021817›Full record

ArticleMedical journal of the Islamic Republic of Iran2025

Clinical Presentation and Chest CT Abnormalities in Adults with

Olga Kupriushina, Rifat Aynetdinov, Svetlana Rachina, Daria Strelkova, Sergey Avdeev, Irina Trofimenko, Vladimir Antonov, Tatiana Yudanova, Maria Agibalova, Olga Ivanova and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Olga KupriushinaI.M. Sechenov First Moscow State Medical University, Hospital Therapy Department №2, Moscow, Russia.
Rifat AynetdinovI.M. Sechenov First Moscow State Medical University, Pulmonology Department, Moscow, Russia.
Svetlana RachinaI.M. Sechenov First Moscow State Medical University, Hospital Therapy Department №2, Moscow, Russia.
Daria StrelkovaI.M. Sechenov First Moscow State Medical University, Hospital Therapy Department №2, Moscow, Russia.ORCID https://orcid.org/0000-0002-2124-0623
Sergey AvdeevI.M. Sechenov First Moscow State Medical University, Pulmonology Department, Moscow, Russia.
Irina TrofimenkoIrkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education, Clinical Allergology and Pulmonology Department, Irkutsk, Russia.
Vladimir AntonovFederal State Budgetary Educational Institution of Higher Education "South-Ural State Medical University" of the Ministry of Healthcare of the Russian Federation, Therapy Department, Chelyabinsk, Russia.
Tatiana YudanovaSmolensk Regional Clinical Hospital, Pulmonology Department, Smolensk, Russia.
Maria AgibalovaState budgetary health care institution of Arkhangelsk region «Kotlas central city hospital named after St. Luke (V.F. Voyno-Yasenetskiy), Clinical Pharmacology Department, Kotlas, Russia.
Olga IvanovaBranch No. 4 of the Federal State Institution «1586 Military Clinical Hospital» of the Ministry of Defense of the Russian Federation, Pulmonology Department, Smolensk, Russia.
Zamira MerzhoevaI.M. Sechenov First Moscow State Medical University, Pulmonology Department, Moscow, Russia.
Anastasia YasnevaI.M. Sechenov First Moscow State Medical University, Hospital Therapy Department №2, Moscow, Russia.
Elena VolosovtsovaI.M. Sechenov First Moscow State Medical University, Pulmonology Department, Moscow, Russia.
Svetlana YatsyshinaCentral Research Institute for Epidemiology of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Laboratory of Molecular Diagnostics and Epidemiology of Respiratory Tract Infections, Moscow, Russia.
Marina TikhonovaCentral Research Institute for Epidemiology of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare, Laboratory of Molecular Diagnostics and Epidemiology of Respiratory Tract Infections, Moscow, Russia.
Inna EdelsteinSmolensk State Medical University, Institute of Antimicrobial Chemotherapy, Smolensk, Russia.
Oksana BarashkoSmolensk Regional Clinical Hospital, Pulmonology Department, Smolensk, Russia.
Olga TiguncevaIrkutsk Order "Badge of Honor" Regional Clinical Hospital, Pulmonology Department, Irkutsk, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The recent increase in the incidence of Methods: We prospectively collected data on hospitalized adults with MCAP during the 2023-2024 outbreak. Clinical manifestation, laboratory data, and radiological abnormalities were evaluated. The data were analyzed using descriptive statistics. Results: A total of 40 patients were enrolled, with a median age of 35 (22; 45) years, and 24 (60%) were male. The primary symptoms were cough (40 patients, 100%), fever (38 patients, 95%), and general weakness (35 patients, 87.5%). Laboratory tests revealed a moderate increase in С-reactive protein levels, with a median of 77.1 (37.3;123.0) mg/L. The most common radiological findings were ground‑glass opacity in 36 patients (90%) and bronchial wall thickening in 33 patients (82.5%). No patients required admission to the intensive care unit, and there were no deaths during the hospital stay. Conclusion: In our study, MCAP predominantly affected young and middle-aged adults with a favorable course and prognosis. The current outbreak requires attention in terms of using optimal diagnostic and treatment methods.

Indexed as

Chest computed tomographyCommunity-acquired pneumoniaMycoplasma pneumoniae

Identifiers

PMID42021817
PMCPMC13097234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.